Study published in Antiviral Research supports promise of Scinai Immunotherapeutics’ coronavirus NanoAb as aerosolized prophylactic and therapeutic drug
Data backs use of Scinai’s aerosolized NanoAbs as a platform for the treatment of hyperinflammatory viral diseases, addressing significant medical needs JERUSALEM, Dec. 11, 2023 /PRNewswire/ — Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developm
A Fresh Online Look for Axia Trade: Introducing an Upgraded, More Responsive Website
ABU-DHABI, United Arab Emirates, Dec. 11, 2023 /PRNewswire/ — In the competitive realm of online brokerage, a platform that is customer-centered, secure, and professional is imperative. Axia Trade, A prominent regulated broker, has presented its new website, reflecting a deep comprehension of
Nexus Children’s Hospital – Shenandoah Responds to Critical Need for Behavioral Care
Opens Doors to Young Patients with Complex Needs THE WOODLANDS, Texas, Dec. 11, 2023 /PRNewswire/ — Nexus Health Systems is partnering with local pediatric hospitals to address the 800% rise in emergency room visits seen by Texas Children’s Hospital from young people with severe mental
/R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Monday, December 11, 2023/
OTTAWA, ON, Dec. 10, 2023 /CNW/ – Note: All times local National Capital Region, Canada Private meetings 5:00 p.m. The Prime Minister will deliver remarks at Hanukkah on the Hill. He will be joined by the Deputy Prime Minister and Minister of Finance, Chrystia Freeland, and the M
Silicon Labs Announces CFO Transition
John Hollister will depart to join partner GlobalFoundries as CFO; CAO Mark Mauldin to be named interim CFO AUSTIN, Texas, Dec. 11, 2023 /PRNewswire/ — Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, announced that John Holliste
HanAll Biopharma’s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ — HanAll Biopharma’s partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson’s disease (PD) and other Nurr1-related human disorders,
Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure
All 15 ibezapolstat-treated patients in Phase 2b who achieved Clinical Cure (CC) at end of treatment (EOT) remained free of C. difficile Infection (CDI) recurrence through one month after EOT, for a Sustained Clinical Cure (SCC) rate of 100% 2 of 14 patients treated with standard of care, oral va
ACAMS Grants 10 CAMS Scholarships in Japan to Bolster Nation’s Anti-Money Laundering Expertise
Initiative supports Japan’s anti-money laundering (AML) and sanctions compliance push WASHINGTON, Dec. 11, 2023 /PRNewswire/ — ACAMS, a leading international membership organization dedicated to the fight against illicit finance, is pleased to announce it has awarded CAMS Scholarships to
China Literature to Acquire Tencent Animation and Comics
HONG KONG, Dec. 11, 2023 /PRNewswire/ — China Literature Limited (“China Literature” or “the Company”, stock code: 0772), a leading online literature and intellectual property (“IP”) incubation platform in China, today announced that it has entered into an
Blue Chip Partners Named a Top Registered Investment Advisory Firm in Michigan by Forbes
Plus, leading wealth management firm launches new educational podcast and investment review series FARMINGTON HILLS, Mich., Dec. 11, 2023 /PRNewswire/ — Blue Chip Partners (“Blue Chip”), an award-winning, independent Registered Investment Advisor (RIA) and comprehensive wealth mana